When it comes to cancer, prostate is the second biggest killer of men in New Zealand - and the number of cases is on the rise. Diagnosis can be invasive and painful - not to mention the additional stress of waiting for biopsy results from a stretched pathology service.
However a team of researchers from the Te Whai Ao Dodd-Walls Centre have developed a potential gamechanger in the detection and diagnosis of prostate cancer.
Led by Dr Claude Aguergaray from the University of Auckland, their laser diagnostic tool is ready for its first clinical trials.
Dr Aguergaray talks to Kathryn Ryan about how it could reduce the number of biopsies and improve surgical outcomes, saving money - and lives.
